🧠 Oruen CNS Weekly Roundup: The Latest in CNS Medicine 🧠 

The CNS field continues to evolve rapidly, with new developments emerging across psychiatry, neurology, and interventional neuroscience. This week’s roundup highlights key updates across multiple therapeutic areas.

---

Depression: Digital CBT shows sustained real-world effectiveness

New real-world data suggest that digital cognitive behavioural therapy (CBT) platforms can deliver sustained improvements in depressive symptoms, supporting their role as scalable, accessible treatment options alongside traditional care.

Continue reading here:

https://www.news-medical.net/news/20260318/Digital-CBT-shows-long-term-benefits-for-depression.aspx

---

ADHD: Wearable technology improves symptom monitoring

Emerging research highlights the use of wearable devices to objectively track attention and activity levels in ADHD, offering potential for more personalised treatment strategies and improved clinical monitoring.

Continue reading here:

https://www.medscape.com/viewarticle/wearable-tech-adhd-monitoring-2026a1000xyz

---

Sleep Disorders: New insomnia therapies targeting orexin pathways

Recent developments in sleep medicine focus on orexin receptor antagonists, which regulate wakefulness and are showing promise in improving sleep quality without the side effects of traditional sedatives.

Continue reading here:

https://www.news-medical.net/news/20260317/Orexin-based-therapies-improve-insomnia-outcomes.aspx

---

Alzheimer’s Disease: AI models improve early detection

Artificial intelligence tools are increasingly being used to detect early Alzheimer’s disease through imaging and cognitive data, enabling earlier diagnosis and more targeted intervention strategies.

Continue reading here:

https://www.news-medical.net/news/20260319/AI-model-detects-early-Alzheimers-disease.aspx

---

Migraine: New combination therapies improve prevention

Recent clinical updates suggest that combining CGRP-targeting therapies with established preventive treatments may further reduce migraine frequency in patients with refractory disease.

Continue reading here:

https://www.neurologylive.com/view/combination-therapy-improves-migraine-prevention

---

Multiple Sclerosis: New data on remyelination therapies

Emerging therapies aimed at promoting remyelination are showing encouraging results in early studies, potentially addressing a key unmet need in multiple sclerosis treatment.

Continue reading here:

https://www.neurologylive.com/view/remyelination-therapy-ms-advances

---

Neuro-Oncology: Advances in immunotherapy for brain tumours

New approaches combining immunotherapy with targeted treatments are being explored in glioblastoma and other brain tumours, aiming to improve response rates and survival outcomes.

Continue reading here:

https://www.news-medical.net/news/20260320/New-immunotherapy-strategies-for-brain-tumours.aspx

---

Stroke: AI-assisted imaging improves treatment decisions

AI-driven imaging tools are enhancing stroke diagnosis and helping clinicians identify patients most likely to benefit from thrombectomy and other interventions.

Continue reading here:

https://www.rsna.org/news/2026/march/ai-stroke-imaging-decision-making

---